
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Creutzfeldt-Jakob disease risk factors
Introduction
Overview
Overview
Risk factors for Creutzfeldt-Jakob disease include advanced age, positive family history, personal history of psychosis, history of surgical procedures, grafts or implants, and history of ingestion of human growth hormones or contaminated meat.
Risk Factors
Risk Factors
Risk factors for Creutzfeldt Jakob disease include the following:
- Advanced age
- Family history of Creutzfeldt-Jakob disease[1]
- Personal history of psychosis[1]
- Multiple surgical or graft procedures, such as electrode implantation, corneal grafting, or dura mater grafting[2]
- Living on a farm for more than 10 yrs[2]
- People receiving human growth hormone (HGH)
- Consumption of contaminated beef (associated with increased risk of variant Creutzfeldt-Jakob disease)[3]
References
References
- ↑ 1.0 1.1 Wientjens, DP.; Davanipour, Z.; Hofman, A.; Kondo, K.; Matthews, WB.; Will, RG.; van Duijn, CM. (1996). “Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies”. Neurology. 46 (5): 1287–91. PMID 8628468. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 Collins, S.; Law, MG.; Fletcher, A.; Boyd, A.; Kaldor, J.; Masters, CL. (1999). “Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study”. Lancet. 353 (9154): 693–7. PMID 10073510. Unknown parameter
|month=ignored (help) - ↑ Ward, HJ.; Everington, D.; Cousens, SN.; Smith-Bathgate, B.; Leitch, M.; Cooper, S.; Heath, C.; Knight, RS.; Smith, PG. (2006). “Risk factors for variant Creutzfeldt-Jakob disease: a case-control study”. Ann Neurol. 59 (1): 111–20. doi:10.1002/ana.20708. PMID 16287153. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
